Abstract
Bronchodilator responsiveness testing combined with clinical evaluation is a critical component for determining a patient's asthma control and management strategy.1 The bronchodilator response depends on several factors, such as severity of airflow obstruction and spirometric parameters considered for the functional response to the bronchodilator agent.2 This study was performed to determine how bronchodilator responsiveness tests are being administered in allergy practices, focusing on compliance and standardization with American Thoracic Society (ATS) guidelines for conducting this test.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Journal of Allergy and Clinical Immunology: In Practice
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
